Mayoly Consumer Healthcare

Mayoly is an independent, family-owned French pharmaceutical group with a significant global presence in gastroenterology and consumer healthcare. The company underwent a major transformation in 2022 by acquiring Ipsen's consumer healthcare business, which integrated well-known global brands such as Smecta, Forlax, and Tanakan into its portfolio. Mayoly operates across several therapeutic areas including digestive health, dermatology, rheumatology, and ENT, offering both prescription and over-the-counter products. The company is vertically integrated, maintaining its own R&D capabilities and manufacturing sites primarily located in France. With a workforce of over 2,000 employees, Mayoly focuses on expanding its international footprint while providing accessible healthcare solutions for common ailments.